DNA Framework-Supported Electrochemical Analysis of DNA Methylation for Prostate Cancers
- 28 August 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 20 (10) , 7028-7035
Abstract
Epigenetic alterations hold great promise as biomarkers for early-stage cancer diagnosis. Nevertheless, direct identification of rare methylated DNA in the genome remains challenging. Here we report an ultrasensitive framework nucleic acid-based electrochemical sensor for quantitative and highly selective analysis of DNA methylation. Notably, we can detect 160 fg of methylated DNA in the presence of a million-fold excess of unmethylated DNA samples using this electrochemical methylation-specific polymerase chain reaction (E-MSP) method. The high sensitivity of E-MSP enables one-step detection of low-abundance methylation at two different genes in patient serum samples. By using a combination test with two methylation alterations, we acquire high accuracy and sensitivity for reliable differentiation of prostate cancer and benign prostate hypertrophy (BPH). This new method sheds new light on translational use in early cancer diagnosis, and monitoring patients’ responses to therapeutic agents.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2016YFA02012, 2018YFF0212803)
- National Natural Science Foundation of China (1671284, 21974147, 61371021)
This publication has 51 references indexed in Scilit:
- Chemically Modified Hydrogel-Filled Nanopores: A Tunable Platform for Single-Molecule SensingNano Letters, 2018
- Abstract 1355: Clinical utility of DNA methylation markers for prostate cancer detection and prognosis: Towards less-invasive molecular diagnostic testsCancer Research, 2014
- Circulating tumour cells and cell-free DNA as tools for managing breast cancerNature Reviews Clinical Oncology, 2013
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysisBritish Journal of Cancer, 2011
- Epigenetic modifications and human diseaseNature Biotechnology, 2010
- Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patientsCancer Letters, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarkerCancer, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004